TRAVERE THERAPEUTICS, INC. Derivative Liability, Current
TRAVERE THERAPEUTICS, INC. (TVTX) had Derivative Liability, Current of $0 as of 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2020-02-24
- 2018-12-31: Derivative Liability, Current $0.00.
- 2018-09-30: Derivative Liability, Current $0.00.
- 2018-06-30: Derivative Liability, Current $0.00.
- 2018-03-31: Derivative Liability, Current $0.00.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-07-06 | |
| 2017-12-31 | $15.70M 10-K · filed 2020-02-24 | $15.71M 10-K · filed 2018-02-27 |
| 2017-09-30 | $20.14M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $22.46M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $21.18M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $22.44M 10-K · filed 2018-07-06 | |
| 2016-09-30 | $28.96M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $33.36M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $24.47M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $38.81M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $42.12M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $91.20M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $63.39M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $27.99M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $18.48M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $25.04M 10-K/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |